REFERENCES
- Ondetti M. A., Rubin B., Cushman D. W. Design of specific inhibitors of angiotensin-converting enzyme:new class of orally active antihypertensive agents. Science 1977; 196: 441–444
- Patchett A. A., Harris E., Tristram E. W., Wyvratt M. J., Wu M. T., Taub D., Peterson E. R., Ikeler T. J., ten Broeke J., Payne L. G., Ondeyka D. L., Thorsett E. D., Greenlee W. J., Lohr N. S., Hoffsommer R. D., Joshua H., Ruyle W. V., Rothrock J. W., Aster S. D., Maycock A. L., Robinson F. M., Hirschmann R., Sweet C. S., Ulm E. H., Gross D. M., Vassil T. C., Stone C. A. A new class of angiotensin converting enzyme inhibitors. Nature 1980; 288: 280–283
- Covol P. New therapeutic prospects of renin-angiotensin system inhibition. Clin. Exp. Hypertens. Theory Practice 1989; 11((suppl. 2))463–470
- Coulter D. M., Edwards I. R. Cough associated with captopril and enalapril. Brit. Med. J. 1987; 294: 1521–1523
- Furukawa Y., Kishimoto S., Nishikawa K. Hypotensive imidazole-5-acetic acid derivatives. US Patent 4 355 040, 1982
- Chiu A. T., Dunica J. V., McCall D. E., Wong P. C., Price W. A., Thoolen M. J. M. C., Carini D. J., Johnson A. L., Timmermans P. B. M. W. M. Nonpeptide angiotensin II receptor antagonists. III. Structure-functionstudies. J. Pharmacol. Exp. Ther. 1989; 250: 867–874
- Wong P. C., Price W. A., Jr., Chiu A. T., Wong N. Y., Dunica J. V., Carini D. J., Johnson A. L., Timmermans P. B. M. W.M. EXP-6803, A nonpeptide angiotensin II receptor antagonist. Cardiovasc. Drug Rev. 1989; 7: 285–300
- Dunica J. V., Chiu A. T., Carini D. J., Gregory G. B., Johnson A. L., Price W. A., Wells G. J., Wong P. C., Calabrese J. C., Timmermans P. B. M. W. M. The discovery of potent nonpeptide angiotensin II receptor antagonists:A new class of potent antihypertensives. J. Med. Chem. 1990; 33: 1312–1329
- Carini D. J., Duncia J. V., Johnson A. L., Chiu A. T., Price W. A., Wong P. C., Timmermans P. B. M. W. M. Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives. J. Med. Chem. 1990; 33: 1330–1336
- Wong P. C., Price W. A., Chiu A. T., Carini D. J., Dunica J. V., Johnson A. L., Wexler R. R., Timmermans P. B. M. W.M. Nonpeptide angiotensin II receptor antagonists: Studies withEXP9270 and DuP753. Hypertension 1990; 15: 823–834
- Mentlo N. B., Chakravarty P. K., Ondeyka D. L., Siegl P. K. S., Chang R. S., Lotti V. J., Faust K. A., Chen T. B., Schorn T. W., Sweet C. S., Emmert S. E., Patchett A. A., Greenlee W. J. Potent, orally active imidazo[4,5-b]pyridine-based angiotensinII receptor antagonists. J. Med. Chem. 1991; 34: 2919–2922
- Duncia J. V., Carini D. J., Chiu A. T., Johnson A. L., Price W. A., Wong P. C., Wexler R. R., Timmermans P. B. M. W.M. The discovery of DuP-753: A potent orally active nonpeptideangiotensin II receptor antagonist. Med. Res. Rev. 1992; 12: 149–191
- Raghavan K., Dwivedi A., Campbell G. C., Jr., Johnson E., Levorse D., McCauley J., Hussain M. A spectroscopic investigation of losartan polymorphs. Pharm. Res. 1993; 10: 900–904
- Naylor E. M., Chakravarty P. K., Chen A., Strelitz R. J., Chang R. S., Chen T. B., Faust K. A., Lotti V. J., Kivlighn S. D., Zingaro G. J., Schorn T. W., Siegl P. K. S., Patchett A. A., Greenlee W. J. (1993) Potent imidazopyridine angiotensin II antagonists, Acylsulfonamides as tetrazole replacements, Abstract of Papers. 206th American Chemical Society National Meeting, Chicago, IL, Aug., 22–271993. American Chemical Society, Washington, DC, Abstract MEDI 76
- Chang R. S. L., Bendensky R. J., Chen T. B., Faust K. A., Kling P. K., O'Malley S. A., Naylor E. M., Chakravarty P. K., Patchett A. A., Greenlee W. J., Clineschmidt B. V., Lotti V. J. In vitro pharmacology of MK-996, A new potent and selectiveangiotensin II (AT1) receptor antagonist. Drug Dev. Res. 1994; 32: 161–171
- Chakravarty P. K., Naylor E. M., Chen A., Chang R. S. L., Chen T. B., Faust K. A., Lotti V. J., Kivlighn S. D., Gable R. A., Zingaro G. J., Schorn T. W., Schaffer L. W., Broten T. P., Siegl P. K. S., Patchett A. A., Greenlee W. J. A highly potent, orally active imidazo-[4,5-b]pyridine biphenylacylsulfanoamide(MK-996; L-159,282): A new AT1-selective angiotensinII receptor antagonist. J. Med. Chem. 1994; 37: 4068–4072
- Byrn S. R. Solid State Chemistry of Drugs. Academic Press, New York 1982
- Ip D. P., Brenner G. S., Stevenson J. M., Lindenbaum S., Douglas A. W, Klein S. D., McCauley J. A. High resolution spectroscopic evidence and solution calorimetrystudies on the polymorphs of enalapril maleate. Int. J. Pharm. 1986; 28: 183–191